Health · 4 views
Current shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure
It is caused by the herpes zoster virus, which can flare up in people who previously had chickenpox. A vaccine against shingles (Zostavax) was introduced in 2006.
AI Summary
A study reported that recipients of the shingles vaccine Zostavax, which has been available since 2006, show a reduced incidence of coronary heart disease, stroke and heart failure. The analysis compared vaccinated older adults with unvaccinated peers, finding the vaccine associated with lower rates of these cardiovascular outcomes. The findings suggest a potential added benefit of the shingles vaccine beyond preventing herpes zoster.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Reserchers confirm cost-effectiveness of mass hepatitis C virus screening among persons in custody in Hong KongContinue reading
- 22 million human immune cells help decode context-dependent gene circuitsContinue reading
- A liver signaling pathway may explain why colorectal cancer weakens muscle and boneContinue reading
- World's first solar ambulance is energy independent while delivering health care in KenyaContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow